SeekingAlphaOctober 14, 2026 at 7:57 PM NY12 Days Ago
Repligen: A Buy As Its Growth Engine Gears Up
Repligen demonstrates 13% organic growth despite Filtration headwinds, with strong momentum in the Proteins and Process Analytics segments. See why RGEN stock is a Buy.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: SeekingAlpha
